Why attend the 4th International Antibody Validation Meeting?
5
Min Read
In this blog:
- We share the latest confirmed speakers at AbVal 2023
- Learn about the meeting sponsors
- Register to attend before the 31st July!
–
We are thrilled to be organising the 4th International Antibody Validation Meeting this September, taking place in the beautiful city of Bath!
This year, we will be reflecting on the progress made since the last meeting held in 2018, dissecting the current state of the field, and looking to the future.
Building on the success of previous meetings, this year we are expanding the number of speakers and length of the event in order to create more space for discussion, making this a meeting not to be missed.
Who is speaking at the meeting?
Now with 18 invited speakers and selected abstract speakers across academia, the biotech/biopharma sector and reagent suppliers, this year’s meeting is lining up to be the largest and most exciting yet.
We are looking forward to welcoming our acclaimed speakers to Bath, including:
- Dean Clift, MRC LMB, UK
- Anthony Couvillon, Mercy BioAnalytics, USA
- Lena D’Hooghe, UCB, UK
- Will Howat, Abcam, UK
- Ibolya Kepiro, National Physical laboratory, UK
- Nicola Lawson, AstraZeneca, UK
- Peter McPherson, McGill University, Canada
- David Piper, Thermo Fisher Scientific, USA
- Asel Sartbaeva, University of Bath/ EnsiliTech, UK
- Jurgen Schmitz, Miltenyi Biotec, Germany
- Mathias Uhlen, SciLifeLab, Sweden
- Antony Wood, Cell Signaling Technology, USA
- Andrea Radtke, NIAID (NIH), USA
- Kevin Harvey, Aviva Systems Biology, USA
- Pierre Cosson, Geneva Faculty of Medicine, Switzerland
- Elena Ivanova, Regeneron, USA
- Katarzyna Kmiecik, Alchemab Therapeutics Ltd, UK
The talks will be spread across 6 sessions over the two and a half day event. For each session, we will have a chair who brings their own wealth of experience and expertise in antibody validation. Confirmed chairs include:
- Carly Dix, AstraZeneca, UK
- Sam Heywood, UCB, UK
- Giovanna Roncador, CNIO, Spain
- Paul Whitley, University of Bath, UK
- Andrew Buchanan, AstraZeneca, UK
Our speakers will be talking on a range of topics, spanning company validation strategies, exciting technologies in the field, interesting validation data and new initiatives.
Here’s a taster of some confirmed talk titles:
- YCharOS: antibody characterization through open science – Peter McPherson
- Accelerating discovery together: A community approach to multiplexed tissue imaging – Andrea Radtke
- Development of a Liquid-Biopsy, Early-Stage Cancer Diagnostic Assay Using Highly Validated, Commercially Available Antibodies – Anthony Couvillon
- Trim-Away: Targeted protein degradation using off-the-shelf antibodies – Dean Clift
We’re really looking forward to discovering more about some innovative work and challenges currently facing the field through these talks.
You can see details of the full programme on the AbVal meeting website as well as all the confirmed talk titles.
What is the format of the meeting?
The meeting will run over 3 days (Wednesday to Friday) at the University of Bath. We will be hosting a drinks reception on the first evening, as well as the ever-popular meeting dinner on the second night right in the centre of the beautiful city of Bath.
We have had posters from around the world submitted, with a dedicated poster session to allow delegates to delve into the details and chat to the presenters. We have had posters from the University of Leicester, Addgene, UCB, the CNIO and more.
As well as the talk sessions, with time for questions for our speakers, we will be holding a discussion forum. We will invite the entire audience to participate in discussion on the key topics relating to antibody validation. This has been very successful at previous meetings, with much of the discussion even continuing on to the conference dinner.
More details will be confirmed soon, so do look out for this!
Antibody Validation Meeting Sponsors
We want to take a moment to thank the sponsors of the 4th International Antibody Validation Meeting: Abcam, Bethyl Laboratories, Bio-Techne, CancerTools.org, Cell Signaling Technology, GeneTex, Miltenyi Biotec, ProSci, Thermo Fisher Scientific, DSHB and the Antibody Society. Without support from the meeting sponsors this event would not be able to happen.
With engaged companies such as these, happy to join in the discussion and present their validations, we are confident antibody validation can continue improving.
See you there?
Registration will officially close on the 31st July, so don’t miss out on the opportunity to attend this unique meeting and support antibody validation.
To register for the event, visit the meeting website.
If you have any questions for the organisation team, do get in touch.
- Rhys and the CiteAb team
